Proteome Sciences (LON:PRM) Shares Down 2.7% – Here’s What Happened

Proteome Sciences plc (LON:PRM) shares fell 2.7% on Tuesday . The company traded as low as GBX 3.60 ($0.05) and last traded at GBX 3.60 ($0.05). 1,183,886 shares were traded during trading, an increase of 573% from the average session volume of 175,815 shares. The stock had previously closed at GBX 3.70 ($0.05).

Proteome Sciences Trading Down 3.1 %

The business’s 50-day moving average price is GBX 4.08 and its two-hundred day moving average price is GBX 3.46. The company has a market capitalization of £10.15 million, a price-to-earnings ratio of -2.49 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a current ratio of 0.20 and a quick ratio of 0.37.

Proteome Sciences (LON:PRM) last announced its quarterly earnings data on Thursday, April 10th. The company reported GBX (1.15) (($0.01)) EPS for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.